Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Clinical Psychiatry

• Publication date

  2008-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.4088/JCP.V69N0114PMID 18312044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The impact of depressive symptoms and psychosocial factors on medication adherence in cardiovascular disease.

  2006cited by this paper
• A prospective evaluation of adherence to medication in first episode schizophrenia

  2006cited by this paper
• Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.

  2006cited by this paper
• Determinants of adherence to osteoporosis treatment in clinical practice

  2006cited by this paper
• Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study

  2006cited by this paper
• A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users.

  2005cited by this paper
• Impact of atypical antipsychotics on outcomes of care in schizophrenia.

  2005cited by this paper
• A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia.

  2005cited by this paper
• Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.

  2005cited by this paper
• A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness

  2005cited by this paper
• Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence

  2004cited by this paper
• Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors.

  2004cited by this paper
• Practice guideline for the treatment of patients with schizophrenia, second edition.

  2004cited by this paper
• Adherence to conventional and atypical antipsychotics after hospital discharge.

  2004cited by this paper
• Role of Ethnicity in Predicting Antipsychotic Medication Adherence

  2003cited by this paper
• A Canadian Programme for Early Intervention in Non-Affective Psychotic Disorders

  2003cited by this paper
• Clinical correlates of early medication adherence: West London first episode schizophrenia study

  2003cited by this paper
• Antipsychotic medication adherence: is there a difference between typical and atypical agents?

  2002cited by this paper
• Predictors of noncompliance in patients with schizophrenia.

  2002cited by this paper
• Medication adherence of individuals with a first episode of psychosis

  2002cited by this paper
• Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder.

  2002cited by this paper
• One year outcome in first episode psychosis: influence of DUP and other predictors.

  2002cited by this paper
• Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996.

  2002cited by this paper
• Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis

  2002cited by this paper
• Time to study discontinuation, relapse, and compliance with atypical or conventional antipsychotics in schizophrenia and related disorders

  2002cited by this paper
• The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches.

  2001cited by this paper
• Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)

  2001cited by this paper
• Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia.

  2001cited by this paper
• Penny-wise and pound-foolish: the impact of measurement error on sample size requirements in clinical trials.

  2000cited by this paper
• Medication adherence in psychosis: predictors and impact on outcome.A 2‐year follow‐up of first‐admitted subjects

  2000cited by this paper
• Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

  1999cited by this paper
• Determinants of medication compliance in schizophrenia: empirical and clinical findings.

  1997cited by this paper
• A depression rating scale for schizophrenics.

  1990cited by this paper
• Insight in Schizophrenia. Its Relationship to Acute Psychopathology

  1989cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper

• Machine learning-based prediction of antipsychotic efficacy from brain gray matter structure in drug-naive first-episode schizophrenia

  2025cites this paper
• Investigation of Anhedonia, Emotional Expression, and Emotion Regulation Difficulties in Individuals Diagnosed with Fibromyalgia.

  2025cites this paper
• First-Episode Psychosis

  2025cites this paper
• Disengagement from treatment and its socio-demographic and clinical predictors among patients with incident schizophrenia in a Nigerian psychiatric hospital: 8-year naturalistic follow-up analysis

  2025cites this paper
• Self-reported attitudes and strategies of physicians towards medication reduction and discontinuation.

  2025cites this paper
• Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocol

  2025cites this paper
• The Effect of Psychopathology and Cognitive Functions on Caregiver Burden in Patients with Schizophrenia.

  2024cites this paper
• Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis

  2024cites this paper
• Improving depressive symptoms in patients with schizophrenia using bilateral bipolar-nonbalanced prefrontal tDCS: Results from a double-blind sham-controlled trial.

  2024cites this paper
• Machine learning prediction model of the treatment response in schizophrenia reveals the importance of metabolic and subjective characteristics.

  2024cites this paper
• Dose-tapering trajectories in patients with remitted psychosis undergoing guided antipsychotic reduction to reach minimum effective dose

  2023cites this paper
• Inflammatory markers of symptomatic remission at 6 months in patients with first-episode schizophrenia

  2023cites this paper
• Exploring the “Insight Paradox” in Treatment-Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine

  2023cites this paper
• Digital Phenotyping in Adults with Schizophrenia: A Narrative Review

  2023cites this paper
• Budget impact of introducing once-every-6-months paliperidone palmitate in US health care plans

  2023cites this paper
• Guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis: a 2-year randomized controlled trial with a naturalistic cohort

  2023cites this paper
• Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders

  2023cites this paper
• High Rate of Discontinuation during Long-Acting Injectable Antipsychotic Treatment in Patients with Psychotic Disorders

  2023cites this paper
• The factor structure and clinical utility of clinician-rated dimensions of psychosis symptom severity in patients with recent-onset psychosis: Results of a 1-year longitudinal follow-up prospective cohort study.

  2022cites this paper
• Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review

  2022cites this paper
• Medication Adherence in a Cross-Diagnostic Sample of Patients From the Affective-to-Psychotic Spectrum: Results From the PsyCourse Study

  2022cites this paper
• Processus de rétablissement

  2022cites this paper
• Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use – a post hoc analysis of the ReLiAM study

  2022cites this paper
• Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists’ Attitudes in Taiwan

  2022cites this paper
• Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature

  2022cites this paper
• Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled Trial of Metformin for Antipsychotic-Induced Weight Gain in Patients with First-Episode Psychosis: A Pilot Study

  2021cites this paper
• Clinical Characteristics of Patients with Schizophrenia Maintained without Antipsychotics: A Cross-sectional Survey of a Case Series

  2021cites this paper
• Protocol of guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis based on pragmatic design

  2021cites this paper
• Antipsychotic medication adherence and preventive diabetes screening in Medicaid enrollees with serious mental illness: an analysis of real-world administrative data

  2021cites this paper
• Comparison of aripiprazole and risperidone effectiveness in first episode non-affective psychosis: Rationale and design of a prospective, randomized, 3-phase, investigator-initiated study (PAFIP-3).

  2021cites this paper
• Challenging the Minimum Effective Antipsychotic Dose During Maintenance: Implications From 10-Year Follow-Up of First Episode Psychosis

  2021influential citation
• Rate and predictors of interrupted patient follow‐up after first‐episode psychosis ‐ a retrospective cohort study in France

  2020cites this paper
• Treatment of Mental Illness Prior to Suicide: A National Investigation of 12,909 patients, 2001-2016.

  2020cites this paper
• The Effects of Combined Social Cognition and Interaction Training and Paliperidone on Early-Onset Schizophrenia

  2020cites this paper
• Medication compliance in outpatients with schizophrenia in one veterans hospital in Taiwan

  2020cites this paper
• Drug‐naïve first‐episode schizophrenia spectrum disorders: Pharmacological treatment practices in inpatient units in Hunan Province, China

  2020cites this paper
• Antidepressive Effect of Antipsychotics in the Treatment of Schizophrenia: Meta-Regression Analysis of Randomized Placebo-Controlled Trials

  2020cites this paper
• Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis

  2020cites this paper
• Evaluation of paliperidone palmitate long‐acting injectable antipsychotic therapy as an early treatment option in patients with schizophrenia

  2019cites this paper
• Measuring the effectiveness of psychoeducation on adherence, depression, anxiety and stress among patients with diagnosis of schizophrenia. a control trial

  2019cites this paper
• Faith and Doubt at the Doctor’s: Class, Race, and the Role of Community in Medical Decision Making

  2019cites this paper
• Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14–18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS)

  2019cites this paper
• Measuring the effectiveness of psychoeducation on adherence, depression, anxiety and stress among patients with diagnosis of schizophrenia. a control trial

  2019cites this paper
• Schizofreniespectrum en andere psychotische stoornissen

  2019cites this paper
• Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first‐episode psychosis cohort

  2019cites this paper
• Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm

  2019cites this paper
• Clinical and Genetic Factors Associated with Resistance to Treatment in Patients with Schizophrenia: A Case-Control Study

  2019cites this paper
• The Association Between Medication Adherence in Mental Illness and Substance Use Disorder Relapse in Patients with Dual Diagnosis

  2018cites this paper
• Antipsychotic-Free Status in Community-Dwelling Patients With Schizophrenia in China: Comparisons Within and Between Rural and Urban Areas.

  2018cites this paper
• Trajectories after first‐episode psychosis: Complement to ambiguous outcomes of long‐term antipsychotic treatment by exploring a few hidden cases

  2018cites this paper
• Non-adherence to antipsychotic medication in first-episode psychosis patients.

  2018cites this paper
• Predicting rehospitalization in patients treated with antipsychotics: a prospective observational study

  2018cites this paper
• Psychosis: clinical insight and beliefs in immigrants in their first episode

  2018cites this paper
• Drug Attitude Inventory In Bipolar I Patients: Psychometric Properties

  2018cites this paper
• Treatment Adherence Among War Veterans with Posttraumatic Stress Disorder: A Concept Analysis

  2018cites this paper
• Continue, adjust, or stop antipsychotic medication: developing and user testing an encounter decision aid for people with first-episode and long-term psychosis

  2018cites this paper
• Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits.

  2018cites this paper
• “Will I need to take these medications for the rest of my life?”

  2018cites this paper
• Factors associated with poor satisfaction with treatment and trial discontinuation in chronic schizophrenia

  2018cites this paper
• Predictors of 'all-cause discontinuation' of initial oral antipsychotic medication in first episode psychosis.

  2018cites this paper
• Clinical Practice Guidelines for Management of Schizophrenia

  2017cites this paper
• Who needs antipsychotic maintenance treatment and who does not? Our need to profile and personalize the treatment of first episode psychosis.

  2017cites this paper
• Identification of Some Risk Factors of Recurrent Relapses Interval Duration in Patients with Schizoaffective Disorder

  2017cites this paper
• Suicide Prevention in Schizophrenia: Do Long-Acting Injectable Antipsychotics (LAIs) have a Role?

  2017cites this paper
• Medication nonadherence among South American patients with schizophrenia

  2017cites this paper
• Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study

  2017cites this paper
• Non-adherence to pharmacological treatment in schizophrenia and schizophrenia spectrum disorders – An updated systematic literature review

  2017cites this paper
• Five-fold increased risk of relapse following breaks in antipsychotic treatment of first episode psychosis.

  2017influential citation
• Treatment persistence and hospitalization rates among patients with schizophrenia: a quasi-experiment to evaluate a patient information program

  2017cites this paper
• Adherence to Medication Regimen in Patients with Severe and Chronic Psychiatric Disorders: A Qualitative Study

  2016cites this paper
• Redefining Medication Adherence in the Treatment of Schizophrenia: How Current Approaches to Adherence Lead to Misinformation and Threaten Therapeutic Relationships.

  2016cites this paper
• Depot-medication compliance for patients with psychotic disorders: the importance of illness insight and treatment motivation

  2016cites this paper
• Title: Psychosis: clinical insight and beliefs in immigrants in their first episode. Running title: Beliefs about psychosis in immigrants Authors:

  2016influential citation
• Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review

  2016cites this paper
• Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Women With Schizophrenia: A Randomized Controlled Trial

  2016cites this paper
• Recommendations for the optimal care of patients with recent‐onset psychosis in the Asia‐Pacific region

  2016cites this paper
• Substance use, medication adherence and outcome one year following a first episode of psychosis.

  2016cites this paper
• The RAISE Connection Program: Psychopharmacological Treatment of People With a First Episode of Schizophrenia.

  2016cites this paper
• Eficacia de quetiapina de liberación prolongada en la sintomatología afectiva Eficcacy of extended release quetiapine in affective symptoms

  2016cites this paper
• Lower rates of consistent urine drug tests for prescribed psychotropic medications among patients on opioid replacement therapy.

  2016cites this paper
• Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients

  2016cites this paper
• Views of early psychosis clinicians on discontinuation of antipsychotic medication following symptom remission in first episode psychosis

  2016cites this paper
• Risk factors for antipsychotic medication non-adherence behaviors and attitudes in adult-onset psychosis.

  2016cites this paper
• Adherencia a la medicación antipsicótica en pacientes indígenas con esquizofrenia

  2016cites this paper
• Cognitive Enhancement Therapy Improves Frontolimbic Regulation of Emotion in Alcohol and/or Cannabis Misusing Schizophrenia: A Preliminary Study

  2016cites this paper
• The readmission rate and medical cost of patients with schizophrenia after first hospitalization - A 10-year follow-up population-based study.

  2016cites this paper
• De behandeltrouw van Mexicaanse Amerikanen met schizofrenie verbeteren met behulp van de theorie van gepland gedrag

  2016cites this paper
• Adaptation and validation of the “tolerability and quality of life” (TOOL) questionnaire in Chinese bipolar patients

  2016cites this paper
• Neurocognitive subtypes of schizophrenia.

  2015cites this paper
• A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders.

  2015cites this paper
• Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.

  2015cites this paper
• [Attributable risk of co-morbid substance use disorder in poor observance to pharmacological treatment and the occurrence of relapse in schizophrenia].

  2015cites this paper
• Efficacy and Safety of Pharmacological and Psychological Interventions for the Treatment of Psychosis and Schizophrenia in Children, Adolescents and Young Adults: A Systematic Review and Meta-Analysis

  2015cites this paper
• Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial.

  2015cites this paper
• The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population

  2015cites this paper
• Relationships among medication adherence, insight, and neurocognition in chronic schizophrenia

  2015cites this paper
• Outpatient Follow-Up Visit after Hospital Discharge Lowers Risk of Rehospitalization in Patients with Schizophrenia: A Nationwide Population-Based Study

  2015cites this paper
• Predictors of poor adherence to treatment in inpatients with bipolar and psychotic spectrum disorders.

  2015cites this paper
• “Long-acting” olanzapine in maintenance therapy of schizophrenia: A study with plasma levels

  2015cites this paper
• Using the theory of planned behavior to improve treatment adherence in Mexican Americans with schizophrenia.

  2015cites this paper